Status:
COMPLETED
Prognostic Value of High Dose Dobutamine Stress Magnetic Resonance Imaging
Lead Sponsor:
Heidelberg University
Conditions:
Coronary Artery Disease (CAD)
Eligibility:
All Genders
18+ years
Brief Summary
High-dose dobutamine/atropine stress cardiac magnetic resonance imaging (DS-MRI) has been incorporated in daily clinical practice for the detection of ischemic heart disease. Thus, wall motion abnorm...
Detailed Description
Background: High-dose dobutamine stress cardiac magnetic resonance imaging (DS-MRI) is incorporated in daily clinical practice for the detection of coronary artery disease (CAD). Purpose: To determine...
Eligibility Criteria
Inclusion
- Written informed consent before the MR-examination
Exclusion
- Non-sinus rhythm, unstable angina, severe arterial hypertension (\>200/120 mmHg), moderate or severe valvular disease and general contraindications to MRI (implanted pacemakers or defibrillators, intracranial metal)
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00837005
Start Date
January 1 2005
End Date
January 1 2012
Last Update
April 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Heidelberg, Department of Cardiology
Heidelberg, Germany, 69120